Abbott Labs - Pharma manufacturing consent decrees

Start Date: 1999
Financial penalties: $212 million
End Date: still pending

Abbott was cited for nonconformance with quality system regulations for in vitro diagnostic products at an Illinois facility. An initial $100-million fine was followed by a $112 million penalty after the company failed a follow-up inspection.

Abbott Labs - Pharma manufacturing consent decrees
Read more on